Orkila Capital invests €15m in Cannamedical

Founder David Henn will retain a 60% stake. SN-Invests, a Luxembourg-based growth investor, is the company's third largest shareholder with a stake of almost 21%.

Cannamedical generates revenues of €1m.

In 2017, Orkila had raised $118m towards a $130m target for its second growth fund, according to an SEC filing. The fund has only made one other investment in a European company. In 2016, Orkila invested an undisclosed sum for a 10-15% stake in Mikkeller, a Danish craft brewer.

Company
Cannamedical was founded in 2016 and employs 40 people in Cologne. It started operating following the legalisation of medical cannabis in Germany in 2017. The company also has subsidiaries in Canada, the UK and Greece.

People
Orkila Capital – Jesse Du Bey (founder, managing partner).
Cannamedical Pharma – David Henn (founder, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Consumer
• Venture
• Germany